Early-stage backers of Rivian, JIMCO seeks MIT spin-off startups that are initiating or improving commercialization efforts across multiple industries - eg. energy, water, mobility.
James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.
Startup Lightning Talks - 2022 MIT Health Science Technologies Conference The Future of Cell & Gene Therapies
Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
"Slowing the aging process of aging by tweaking the body’s metabolism", Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health